NCT03613831

Multi-center Complex Atrial Tachycardia High-Resolution Mapping Registry (MATH)

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is an observational study without any hypothesis testing. It intended to observe the clinical application of electrophysiological mapping and catheter ablation of atrial tachycardia post atrial fibrillation ablation or cardiac surgery guided with Rhythmia System.

Conditions

• Atrial Tachycardia (Including Atrial Flutter) Post Atrial Fibrillation Ablation or Cardiac Surgery

Interventions

Type	Name	Description
DEVICE	patient who used Rhythmia system and Orion catheter	suitable for Rhythmia system and Orion catheter according to relevant clinical guidelines and products instruction for use, per investigator's discretion

Timeline

• Start date: 2020-12-01
• Primary completion: 2022-12-01
• Completion: 2023-02-01
• First posted: 2018-08-03
• Last updated: 2020-09-01

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated device study